NEVER DISSOLVE YOUR FILLER || Hyaluronidase

Novavax Statement on Arrival of its COVID-19 Vaccine in Canada

 

Mar 31, 2022

Deliveries of Novavax’ COVID-19 vaccine continue around the world, with doses arriving in Canada on March 29. Health Canada granted authorization for Nuvaxovid™ COVID-19 Vaccine (Recombinant protein, Adjuvanted) for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 18 years of age and older last month.

Nuvaxovid is the only protein-based COVID-19 vaccine granted authorization from Health Canada and offers an alternative option to the current portfolio of vaccines. Release procedures are underway, as required with all vaccines, and it is anticipated that the vaccine will be available to Canadians in the coming weeks.

For more information on Nuvaxovid, including the Summary of Product Characteristics with Package Leaflet, Prescribing Information and Important Safety Information, adverse event reporting instructions, or to request additional information, please visit the following websites:

• Health Canada
• Novavax global authorization website

Wrinkle Injections:

Wrinkle Injections:  :  

Novavax files for COVID-19 vaccine authorization with Health Canada

Novavax files for COVID-19 vaccine authorization with Health Canada: 

Novavax filed for authorization with Health Canada today for its protein-based COVID-19 vaccine. Stanley Erck, President & CEO, Novavax tells BNN Bloomberg that its vaccine can be mixed & matched with others and that it's scaling production globally.

Hopes unvaccinated will get Novavax as new COVID-19 vaccine, drugs appro...

Canada is 'doing it right' on COVID vaccine strategy: Novavax CEO

Canada is 'doing it right' on COVID vaccine strategy: Novavax CEO: 

The Canadian government and Novavax have signed a deal for the company to produce its COVID-19 vaccine at a facility on Montreal, which could produce up to two million vaccines per month. Novavax CEO, Stanley Erck, joins BNN Bloomberg to discuss.

Canada is 'doing it right' on COVID vaccine strategy: Novavax CEO

Canada is 'doing it right' on COVID vaccine strategy: Novavax CEO: 

The Canadian government and Novavax have signed a deal for the company to produce its COVID-19 vaccine at a facility on Montreal, which could produce up to two million vaccines per month. Novavax CEO, Stanley Erck, joins BNN Bloomberg to discuss.